Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro in a country that has been called the world’s diabetes capital.

Professor Chris van Tulleken, a BBC TV doctor, told MPs that the nation is facing an 'obesity pandemic' which is being driven ...

While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

It’s estimated that more than 5.8 million people in the UK are living with diabetes, which is an all-time high, according to Diabetes UK ...

A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections ...

Diet and exercise were associated with improved psychologic symptoms among patients with moderate baseline symptoms, osteoarthritis, and obesity.

MAHA advocates are skeptical of President Donald Trump's deal to lower drug prices for GLP-1 anti-obesity drugs.

The Trump administration is planning to release dietary guidelines in December aimed at reducing the high rates of obesity ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...

New data shows which are America's most and least overweight states, based on an evaluation of measures like obesity rates, ...